CNBC's "Fast Money"

Listen to our traders take you behind the money...how to play the volatility...pops and drops and the movers you missed. Fast Money Disclaimer

Transcribed - Published: 6 January 2026

Stocks rallying to start the week after the U.S. action in Venezuela and the capture of leader Nicolas Maduro. How oil and energy are leading the charge, and if larger geopolitical conflicts will follow. Plus an exclusive interview with Nvidia CEO Jensen Huang, fresh off the stage of the company’s CES event in Las Vegas. His take on AI, robotics, competition, and more. Fast Money Disclaimer

Transcribed - Published: 5 January 2026

Major markets kicked off the year well off their session highs, but what stage does the action set for the rest of the new year? We’ll debate. Plus Tesla deliveries drop and it’s lost its spot at the top of the EV race. But will robotaxis and robots help it regain its footing? Fast Money Disclaimer

Transcribed - Published: 2 January 2026

2025 trading is in the books, with the S&P 500 locking in a 16% gain. How our traders are positioning into the new year after solid runs in some major stocks, and where they see the most opportunity in 2026. Plus, Charting out UnitedHealth’s next move. After a rough year for shares of the insurance giant, the Chartmaster Carter Worth is seeing some positive signals in the beaten down name. The key levels to watch, and where that stock could head in the new year. Fast Money Disclaimer

Transcribed - Published: 31 December 2025

Big Banks on pace for a standout year. The money centers with double digit gains, and if the financials sector can stay on focus in 2026. Plus New Year, New interest in AI? What the VC landscape is looking for in the red-hot AI space, and where an early stage investor sees the most opportunity. Fast Money Disclaimer

Transcribed - Published: 30 December 2025

Is the fever breaking in the AI & metals trade? The chip & tech stocks seeing outsized drops, and how Silver reversed course in a major way after hitting records. Plus the next move for the tech trade after a standout year, and the stocks one top analyst is betting on in 2026, but Nvidia isn’t one of them. Fast Money Disclaimer

Transcribed - Published: 29 December 2025

Precious metals prices have surged this year, hitting all-time highs and far outpacing the stock markets. What’s in store for the trade in the new year, and can the gains keep coming? Plus the holiday shopping season is officially in the books. Who came out on top, and how is the long-strapped consumer set up for 2026? Fast Money Disclaimer

Transcribed - Published: 26 December 2025

The S&P 500 closing at a fresh record high, as commodities come along for the ride. If the metal moves in Gold, Silver, and Copper can keep rocking into the new year, and how this morning’s strong GDP report will impact the Fed’s next rate decision. Plus Shares of Novo Nordisk on the move as the pharma company’s weight loss pill gets approved by the FDA. How the decision can tip the scales for Novo, and what one analyst sees in store for the weight loss drug space. Fast Money Disclaimer

Transcribed - Published: 23 December 2025

Another chapter in the battle for Warner Brothers Discovery, as Larry Ellison steps in to back Paramount Skydance’s offer. How the father & son combo could help seal a deal, and where the development puts Netflix. Plus the financial sector just underperforming the broader market this year, but could 2026 see a bank breakout? Why one bank researcher says there’s big opportunity in small banks. Fast Money Disclaimer

Transcribed - Published: 22 December 2025

Just a few trading days left in 2025, and there’s an AI battle royale brewing between hardware and hyperscalers. The moves in Micron, Nvidia, and Oracle as Mag-7 hyperscalers largely sit out of today’s rally. Plus A TikTok spinoff deal, and an $11B weapons package to Taiwan. All the headlines swirling around U.S.-China relations, and how it can all impact global markets. Fast Money Disclaimer

Transcribed - Published: 19 December 2025

Nike and Fedex on the move after reporting results. The details from those quarters, and why today’s delayed CPI data isn’t calming one market forecaster's inflation worries. Plus Shares of Insmed taking a dive as the company discontinues development of a key drug after disappointing trial results. What it means for Insmed’s future, and what one health care analyst sees in store for the broader sector. Fast Money Disclaimer

Transcribed - Published: 18 December 2025

Shares of Oracle take a hit as Blue Owl reportedly won’t back the company’s $10B data center in Michigan. What it means for the stock as it hits levels not seen since mid-June, and how it’s impacting the broader AI trade. Plus Volatility spiking as stocks sell off. What the uptick in stock swings mean for markets heading into year end, and how you can position your portfolio with a new year on the horizon. Fast Money Disclaimer

Transcribed - Published: 17 December 2025

Crude continuing its crumble as WTI dips below $55 a barrel. The next move for the energy sector as it struggles to see any gains this year. Plus Why Jefferies’ David Zervos still sees a goldilocks scenario in play for the market as we head into year end. Fast Money Disclaimer

Transcribed - Published: 16 December 2025

Shares of Ford on the move after the automaker announced a $19.5b write off of its electric vehicle business. What the company is focusing on now, instead. Plus Terns Pharmaceuticals announced positive results for its new cancer drug last week. The CEO joins to lay out next steps for the company. Fast Money Disclaimer

Transcribed - Published: 15 December 2025

Shares of Broadcom and Oracle suffer from “AI Angst” to end the week, taking a bite out of tech stocks and the broader market. Plus news President Trump will soon reclassify marijuana as a much less-regulated Schedule III drug sending shares of pot stocks sharply higher. Fast Money Disclaimer

Transcribed - Published: 12 December 2025

In our last Fast Money Live event of the year, the traders dig into Broadcom and Lululemon earnings, as well as Disney’s deal with Open AI. Plus, we’re answering our biggest fans’ most burning investing questions, and bringing you a couple holiday surprises! Fast Money Disclaimer

Transcribed - Published: 11 December 2025

The Federal Reserve cutting rates by a quarter point, as expected, at its last meeting of the year, and stocks rose on the news, with the S&P finishing the day just shy of a record. Meanwhile Oracle shares were dropping after its latest earnings report. The traders dive into all the details from the call. Fast Money Disclaimer

Transcribed - Published: 10 December 2025

JPMorgan shares closed near their lows of the day after its consumer banking head said expenses would be 10% higher next year. The implications for the banking sector and the broader market. Plus Walmart shares are trading near a $1 trillion valuation. But one top technician says he’s still long the name. Fast Money Disclaimer

Transcribed - Published: 9 December 2025

Yields around the world are on the rise as global central banks weigh whether to cut rates before year-end. What this means for the markets, and whether there are more cuts to come. Plus a hostile bid from Paramount Skydance. But will Warner Bros. shareholders side with David Ellison’s company or Netflix. The future of the streaming landscape and the stocks. Fast Money Disclaimer

Transcribed - Published: 8 December 2025

Shares of Oracle have lost nearly 40% since their last blowout earnings report three months ago. The traders weigh in on what they expect to hear when the company releases its latest results next week. Plus, should WBD shares have popped even higher than they did today? We find out why gains weren’t as strong as Netflix’s bid. Fast Money Disclaimer

Transcribed - Published: 5 December 2025

Chatter over President Trump’s next Fed Chair pick is heating up. The latest being heard from D.C., and the front runners likely to take over for Jerome Powell. Plus, just a few weeks left of trading this year, and 2026 could see another double digit gain in the S&P 500. What Morgan Stanley’s Mike Wilson sees in store for stocks, and the sectors he says has the most opportunity. Fast Money Disclaimer

Transcribed - Published: 4 December 2025

Could Crude Oil be the new Gold? How the commodities rough year could give way for a high energy trade, and replace the glittering gold rally. Plus Microsoft on the defensive, as the tech giant pushes back against reports its lowering AI sales growth goals. Why one top tech analyst is siding with the company, and what he sees in store for the broader AI trade. Fast Money Disclaimer

Transcribed - Published: 3 December 2025

Apple closing at a record high, as the tech giant continues its recent outperformance over the broader market. But could Apple get left behind as the AI race speeds higher, or can the company keep up with its mega cap peers? Plus, What the Chartmaster Carter Worth sees in the energy sector’s technicals, the comments sending shares of Boeing soaring, and all the after-hours action in names like Crowdstrike, Marvell, and more. Fast Money Disclaimer

Transcribed - Published: 2 December 2025

Bitcoin feeling the Thanksgiving hangover as the crypto space sells off. The tokens leading the losses, and how the Bitcoin treasury companies are feeling the pain as well. Plus Why the AI tech rally can keep rocking in the new year. Where one top tech analyst sees the most opportunity, as investors digest the latest AI power partnership. Fast Money Disclaimer

Transcribed - Published: 1 December 2025

Around the country, a pervasive question being asked: How can I afford my prescription drugs? The high cost of those medications, particularly very expensive drugs to treat serious diseases like multiple sclerosis and cystic fibrosis, have fueled a nationwide business in which insurance programs are using companies called “alternative funding programs” or AFPs that promise to get these medications at little or no cost to the patient. “RiskyRX,” a CNBC investigation, found AFPs are becoming more pervasive around the country as drug costs skyrocket. CNBC submitted nearly 100 public records requests and sorted through more than 10,000 pages of contracts, emails, invoices and complaints that show these companies have penetrated the country’s health-care system through private employers, cities, counties, school districts and unions. In some cases, employers require their staff to use an AFP. CNBC traced the trail of medications from abroad to the U.S. via a supply chain that’s not authorized by the pharmaceutical companies that manufacture the medications. The investigation features an exclusive interview with a Department Of Homeland Security official who says these programs should be shut down because they’re illegal and post a serious safety risk to patients. A former high-ranking FDA official, speaking out for the first time, says these programs typically don’t disclose the risks to patients. The AFPs strongly defend their business practices as both legal and safe and say their businesses are an antidote to high prescription drug prices. Those prices, across all drugs, in the U.S. are nearly three times as much, on average, as those in other high-income countries, according to a 2024 report by Rand, a nonprofit, nonpartisan research organization.

Transcribed - Published: 27 November 2025

Listen to our traders take you behind the money...how to play the volatility...pops and drops and the movers you missed. Fast Money Disclaimer

Transcribed - Published: 26 November 2025

Listen to our traders take you behind the money...how to play the volatility...pops and drops and the movers you missed. Fast Money Disclaimer

Transcribed - Published: 25 November 2025

Listen to our traders take you behind the money...how to play the volatility...pops and drops and the movers you missed. Fast Money Disclaimer

Transcribed - Published: 24 November 2025

Stocks closing out the week with a big leg higher, as equities rebound after an Nvidia led sell-off on Thursday. The sectors gaining ground, and if the volatility will continue into a shortened holiday week. Plus Rounding up all the retail data and results that came in this week, the huge move in airlines, restaurants, and housing stocks, and where to find opportunity in the credit markets. Fast Money Disclaimer

Transcribed - Published: 21 November 2025

An early rally in stocks gave way to a rough sell-off on Wall Street. How Nvidia’s reversal, and a delayed jobs report gave way to a market meltdown, and how Walmart became a bright spot in the down day. Plus, Biotech more than doubling the performance of the broader market, as M&A action lights up the space. Where our next guest sees the most opportunity in the space, and if the biotech boom can continue into year end. Fast Money Disclaimer

Transcribed - Published: 20 November 2025

Nvidia on the move after reporting results. The numbers and details from their latest quarter, and what a top semi analyst sees in store for the chip giant. Plus Shoppers skipping the trips to Target. The disappointing numbers out of the retailers results, and the implications it could have ahead of the holiday season. Fast Money Disclaimer

Transcribed - Published: 19 November 2025

Amazon and Microsoft getting hit on lingering concerns over AI’s sky-high valuation. What analysts are flagging about the buildout, and what it all means ahead of Nvidia’s earnings report tomorrow. Plus Why one analyst says the weakness in health care stocks is a major buying opportunity, the sports betting drama between Draftkings, Fanduel, and the American Gaming Association, and the next move for nuclear stocks after a rough month for the group. Fast Money Disclaimer

Transcribed - Published: 18 November 2025

Shares of Nvidia down nearly 10% in November as the semi giant gears up to report results on Wednesday. How our traders are positioning ahead of that report, and what Jim Cramer sees in store for the AI darling heading into year end. Plus Could Tesla be about to charge higher? Shares nearly flat on the year, but one wall street firm is plugging into the EV maker for its next leg higher. What they say could power the move, and just how high this stock can go. Fast Money Disclaimer

Transcribed - Published: 17 November 2025

Stocks stage a comeback after waking up on the wrong side of the bed this morning. How the S&P 500, Nasdaq, crypto, and momentum stocks bounced off their bottoms of the day, and what it means for the market setup next week. Plus The latest M&A action on the horizon in the pharma space. What one top analyst sees in store for the sector, and the names on his radar with the best prognosis. Fast Money Disclaimer

Transcribed - Published: 14 November 2025

Markets selling off as concerns over the interest rate outlook take center stage. The missing data and housing market stats pushing stocks lower, and where the traders are finding safety in the storm. Plus Disney drops as the media giant prepares for a lengthy YoutubeTV battle, Bitcoin tumbles below $100K, and how Chinese hackers used AI to attack organizations across the globe. Fast Money Disclaimer

Transcribed - Published: 13 November 2025

Shares of Oracle lower again today, as the post-earnings pop continues to fade for the semi giant. The impact it’s having on the rest of the megacap tech names, and where our traders see the AI trade heading next. Plus Lacing up ahead of the holidays, as On Holdings surges after reporting results. The momentum they’re seeing, and what one former retail exec sees in store for the industry heading into year end. Fast Money Disclaimer

Transcribed - Published: 12 November 2025

Biotech sees a breakout, as the group keeps up with the Mag7 stocks this year. The names leading that charge, and the prognosis for the group heading into year end. Plus, An AI warning for the real estate sector. Why one industry giant is flagging potential job cuts, and the next move for the space as rates decline. Fast Money Disclaimer

Transcribed - Published: 11 November 2025

Tech stocks seeing a rebound with an end to the government shutdown in sight. How Coreweave’s latest results are moving that name, and the action in Semis, software, and more. Plus A Retail Would You Rather, as Walmart and Target gear up for a holiday surge. Who are our traders are sticking with, and the next move in those names. Fast Money Disclaimer

Transcribed - Published: 10 November 2025

Stocks bouncing off their lows of the session as Democrats offer to end the government shutdown in exchange for an extension of the health care tax credit. If a deal can get done, and how it’s impacting stocks after a rough week. Plus The Fast Money traders are going bargain hunting. The names they’re watching amid the volatility, and if their picks can boost your portfolio. Fast Money Disclaimer

Transcribed - Published: 7 November 2025

Stocks selling off as AI valuations spook investors, with Big tech leading the losses. Why one of our traders is flagging hyperscaler debt, and how it could impact the group’s next move. Plus Consumer concerns coming to the surface. How a tale of two consumers is unfolding, and the affect it could have on the economy. Fast Money Disclaimer

Transcribed - Published: 6 November 2025

Earnings are filtering in, and companies are seeing a tale of two very different consumers. The group raising concerns about their customer base, and the names not seeing any slowdown. Plus Novo and Eli Lilly nearing a deal with the White house to lower obesity drug prices. What it means for the space, and how it could change medicare coverage of the weight loss drugs. Fast Money Disclaimer

Transcribed - Published: 5 November 2025

Skyhigh valuations finally weighing on stocks as investors roll out of the risk-on trade. The details behind the drop in Palantir, the crypto trade, and if there’s more pain to come. Plus a lot of technical jargon to know, and Katie Stockton is closing the gap on some of the lingo. What you need to know about technical analysis, and the names she’s watching. Fast Money Disclaimer

Transcribed - Published: 4 November 2025

Both the risk-on crypto space and the risk-off defensive staples sector getting hit today. What the dual downer means for the market, and how the Fast Money traders are positioning for November. Plus Shares of Insmed nearly tripling in 2025. What the CEO sees in store for the company as they rollout their chronic lung disease drug. Fast Money Disclaimer

Transcribed - Published: 4 November 2025

Stocks wrapping up a not-so-spooky October, with the major indices all notching solid gains. The names helping boost the Nasdaq, and why boosted AI capex spending in two tech giants are sending the stocks in very different directions. Plus A streaming scoop up. How Netflix could be eyeing Warner Brothers assets, and how it could impact the media space. Fast Money Disclaimer

Transcribed - Published: 31 October 2025

Apple & Amazon the latest big tech names to report results. The headlines from the company conference calls, and what top tech analyst Gene Munster sees in store for the group. Plus Eli Lilly jumping as its obesity drug sales soar. How the company is moving the needle in the weight loss wars, and the other pharma stocks moving on potential M&A action. Fast Money Disclaimer

Transcribed - Published: 30 October 2025

Stocks hitting fresh record highs before pulling back as the Fed cuts interest rates for the second time this year. What Chair Powell had to say about the labor market, inflation, and the central bank’s December meeting. Plus, Big Tech reporting results, as Alphabet, Microsoft, and Meta all deliver results. The details from the company conference calls, and what a top tech analyst sees in store for the group post earnings. Fast Money Disclaimer

Transcribed - Published: 29 October 2025

All eyes on the Federal Reserve ahead of tomorrow’s rate decision. The data, or lack there of, helping shape the central bank’s next move, and how broader markets will respond. Plus Waiting on interest rates to drop? Don’t hold your breath. Why a top mortgage economist says it may be years before we see rates drop below 6%, and the impact it could have on the housing sector. Fast Money Disclaimer

Transcribed - Published: 28 October 2025

Shares of Qualcomm surging as the chipmaker announces a new AI accelerator chip. How it positions the company in the data center duels, and the semi surge its bringing to the rest of the space. Plus Japan, Argentina, and China all ticking higher as positive trade headlines move markets. Where the traders are looking for the best opportunities abroad, and the international exposure that could boost your portfolio. Fast Money Disclaimer

Transcribed - Published: 27 October 2025

Stocks rallying to record highs as long-awaited CPI data comes in lower-than-expected. How the latest inflation read could pave the way for more rate cuts by the Fed at next week’s meeting, and how the traders are positioning ahead of the busiest week of earnings season. Plus, the options action on the Mag7 names reporting, and why nuclear stocks are going radioactive on a new power deal. Fast Money Disclaimer

Transcribed - Published: 24 October 2025

Intel on the move as results cross the wires, as memory chip stocks rally on reports of higher prices. Plus, how one derivatives strategist is navigating AI volatility ahead of Mag7 earnings, the jump in crude oil as new sanctions on Russia comes into focus, and the leap in quantum stocks as the White House reportedly eyes the space for its next equity stake. Fast Money Disclaimer

Transcribed - Published: 23 October 2025